1. Performance Achievement in the assigned territory
Ensure listing of the BI products as required
Ensure availability of BI products as required
Generate Rx / create demand for BI product by utilizing the available resource / tools / trainings
Ensure Rx are filled and demand is converted into performance
Continuosly identify new growth opportunities
2. Execute Performance Action Plans with excellence
Validate and fully understand the Business Action Plans
Plan for logistics to execute the Busisness Action Plans
Take proactive decision to ensure that high value customer (Gain, Build, Defend) are not missed
3. Customer Relationship Management
Maintain correct and complete customer data base
Develop / Validate effective Business Action Plans
Track achievement of Busisness Action Plans and take corrective actions to ensure that Gain,Build, Defend customer are met on priority
Utilize Veeva functions like Event Management to record an event, survey function to conduct surveys, CfE function for coaching
4. Superior Selling Capability-
Knowledge (Disease,Clinical Trials,Product,Marketing strategy and Competition)
Selling Skills (CEM) in line with Marketing strategies
5. Comply with local regulations, industry and company Code of Conduct
Comply with all regulations regarding interactions with healthcare professionals and follow company Code of Conduct
Take necessary action on issues of compliance
Be a role model in compliance with local regulations, industry and company code of conduct
at least 1 year experience
graduate in Pharmacist
good communication, presentation.
Our Culture :
Boehringer Ingelheim is a research-driven pharmaceutical company and one of the top 20 pharmaceutical firms worldwide. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally in over 100 countries and has more than 48,000 employees.
The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
In 2016, Boehringer Ingelheim achieved net sales of about 15.9 billion euros. R&D expenditure corresponds to 19.6% of its net sales.